Annual report pursuant to Section 13 and 15(d)

CONSOLIDATED BALANCE SHEETS

v3.23.1
CONSOLIDATED BALANCE SHEETS - USD ($)
Dec. 31, 2022
Dec. 31, 2021
Current assets:    
Cash $ 68,615 $ 85,838
Accounts receivable 35,378 1,500
Grant receivable 130,152 56,359
Prepaid expenses 82,765 84,629
Total current assets 316,910 228,326
Property and equipment, net 76,572 102,843
Right to use assets 270,406 384,921
Other assets:    
Patents, net 10,206 11,385
Software development costs 47,980 47,980
Deposits, long term 44,520 44,520
Total other assets 102,706 103,885
Total assets 766,594 819,975
Current liabilities:    
Accounts payable and accrued expenses, including related party payables of $1,077,088 and $1,014,892, respectively 3,907,954 3,188,560
Deferred revenue, short term 33,256 34,981
Lease liability, short term 134,343 119,733
Notes payable, net of debt discount of $23,878 and $0, respectively 297,602 221,480
Notes payable, related parties, net of debt discount of $49,473 and $0, respectively 990,637 790,110
Paycheck Protection Program loan, short term 0 31,580
Total current liabilities 5,363,792 4,386,444
Long term liabilities:    
Paycheck Protection Program loan, long term 0 99,860
Economic Injury Disaster loan, long term 73,850 74,300
Royalty obligation - net of discount of $5,376,790 and $5,854,226, related parties 3,345,310 2,867,874
Lease liability, long term 181,328 315,672
Deferred revenue, long term 4,045 37,301
Total liabilities 8,968,325 7,781,451
Commitments and contingencies (Note 19) 0 0
Deficit:    
Common stock, $0.001 par value; 750,000,000 shares authorized, 7,718,636 and 6,698,968 shares issued and outstanding as of December 31, 2022 and 2021, respectively 7,719 6,699
Common stock subscribed 100,000 100,000
Additional paid in capital 66,130,296 62,994,739
Accumulated deficit (74,336,105) (69,966,692)
Total deficit attributable to BioCorRx, Inc. (8,076,474) (6,843,638)
Non-controlling interest (125,257) (117,838)
Total deficit (8,201,731) (6,961,476)
Total liabilities and deficit 766,594 819,975
Convertible Series A Preferred Stock [Member]    
Deficit:    
Preferred stock, value 16,000 16,000
Convertible Series B Preferred Stock [Member]    
Deficit:    
Preferred stock, value $ 5,616 $ 5,616